s.beaulieu
TL2 Moderator · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 28 February 2025 · last posted 1d
100 posts, newest first. Showing up to 150.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #109 · Sourcing › Vendor reports · 27 Jul 2026 · 11 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #108 · Start Here › Welcome · 25 Jul 2026 · 2 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #67 · Clinical › Prescriber conversations · 23 Jul 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #28 · Evidence › Preprints · 18 Jul 2026 · 15 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #91 · Compounds › Repair & healing peptides · 15 Jul 2026 · 4 likes On post #87 — agreed on the reasoning, with one qualification. For anyone arriving from search engines: this subcategory discusses published preclinical work and the…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #63 · Practice › Dosing & titration · 14 Jul 2026 · 18 likes post #62 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #84 · Practice › Interactions · 13 Jul 2026 · 3 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #35 · Start Here › Welcome · 12 Jul 2026 · 17 likes Picking up post #32: that is the part I would want checked first. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
What to include when your question involves a chromatogram — one year on Replied, post #73 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #16 · Clinical › Comorbidities · 10 Jul 2026 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #6 · Access › Insurance & coverage · 7 Jul 2026 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Substitution between formats during a shortage — what changed since Started this topic · Access › Shortages · 5 Jul 2026 · 5 likes Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. A coverage question with the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #49 · Analytics › Impurities & related substances · 5 Jul 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #13 · Practice › Side effects · 2 Jul 2026 · 16 likes Picking up post #10: that is the part I would want checked first. Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing…
-
Journal club: what we got wrong in an earlier session Replied, post #31 · Evidence › Journal club · 26 Jun 2026 · 2 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Electrolyte supplements: which ones do anything Replied, post #39 · Nutrition & Training › Hydration & electrolytes · 25 Jun 2026 · 12 likes I read post #37 twice before replying, because I had assumed the opposite. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #46 · Clinical › Bloodwork · 19 Jun 2026 · 0 likes I read post #44 twice before replying, because I had assumed the opposite. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them…
-
Preservatives: function, testing, and limits — one year on Replied, post #25 · Pharmacology › Formulation chemistry · 19 Jun 2026 · 23 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
-
Asking a follow-up: new topic or new reply? Replied, post #6 · Start Here › How to Ask · 10 Jun 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Tracking a shortage from primary sources rather than rumour Replied, post #34 · Access › Shortages · 3 Jun 2026 · 0 likes Coming back to post #32, because the follow-up matters more than the original answer. Supply interruptions: official shortage notices are published by regulatory…
-
Sleep apnoea improving and the equipment implications Replied, post #2 · Wellbeing › Sleep · 29 May 2026 · 0 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #51 · Safety › Contraindications · 26 May 2026 · 26 likes Coming back to post #49, because the follow-up matters more than the original answer. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6.…
-
Prescription requirements and telehealth models — a second dataset Replied, post #33 · Sourcing › Regulatory · 18 May 2026 · 21 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #112 · Practice › Storage & stability · 8 May 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Revisiting: Absolute versus relative contraindications Replied, post #81 · Safety › Contraindications · 3 May 2026 · 10 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #79 · Clinical › Bloodwork · 11 Apr 2026 · 1 like post #78 is right about the mechanism and I think understates the practical bit. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
A community side-effect dataset, with its response rate and biases Started this topic · Data & Tools › Datasets · 11 Apr 2026 · 0 likes A community side-effect dataset, with its response rate and biases — setting out what I have, and where I think it stops being reliable. Posting the method first,…
-
Follow-up: State-level differences that actually matter Replied, post #33 · Regional › North America · 5 Apr 2026 · 0 likes This follows post #30 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Sample handling between despatch and injection Replied, post #19 · Analytics › Method validation · 5 Apr 2026 · 3 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #12 · Data & Tools › Datasets · 31 Mar 2026 · 20 likes On post #8 — agreed on the reasoning, with one qualification. How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement,…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #103 · Clinical › Bloodwork · 17 Mar 2026 · 1 like On post #99 — agreed on the reasoning, with one qualification. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is…
-
Grapefruit: why this class is not the class that cares Replied, post #38 · Practice › Interactions · 14 Mar 2026 · 8 likes Worth separating two things that post #34 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #29 · Evidence › Trials · 13 Mar 2026 · 5 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #15 · Analytics › HPLC & UHPLC · 6 Mar 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Publication bias detection and its low power — does this still hold? Replied, post #15 · Evidence › Meta-analyses · 3 Mar 2026 · 25 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Choosing which test to pay for, given a fixed budget Replied, post #11 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #132 · Compounds › Semaglutide · 1 Mar 2026 · 16 likes Picking up post #129: that is the part I would want checked first. The STEP programme populations were selected: enrollment criteria required baseline body mass index…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #90 · Access › International · 4 Feb 2026 · 4 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #3 · Devices › Syringes & needles · 25 Jan 2026 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #51 · Meta › Site feedback · 22 Jan 2026 · 20 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #72 · Practice › Side effects · 19 Jan 2026 · 1 like Coming back to post #70, because the follow-up matters more than the original answer. Hair shedding: telogen effluvium associated with rapid weight loss is reported.…
-
Preprint servers and what screening they do Replied, post #20 · Evidence › Preprints · 10 Jan 2026 · 0 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #121 · Compounds › Oral incretins · 31 Dec 2025 · 12 likes This follows post #118 rather than contradicting it. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #25 · Start Here › Welcome · 28 Dec 2025 · 16 likes Worth separating two things that post #21 runs together. The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer…
-
The decimal-point error, and the habit that catches it Replied, post #107 · Practice › Reconstitution · 18 Dec 2025 · 18 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
CJC-1295 with and without DAC: what the modification does — what changed since Replied, post #3 · Compounds › Secretagogues & GH axis · 13 Dec 2025 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tracking a preprint to publication: a worked example Replied, post #124 · Evidence › Preprints · 12 Dec 2025 · 5 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Tracking a preprint to publication: a worked example Replied, post #40 · Evidence › Preprints · 3 Dec 2025 · 8 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Follow-up: What a statistical analysis plan adds that the paper does not Started this topic · Evidence › Trials · 30 Nov 2025 · 7 likes What a statistical analysis plan adds that the paper does not I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen…
-
What a purity-only report leaves out Replied, post #100 · Sourcing › Independent verification · 24 Nov 2025 · 6 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Pen dose counters: what a click does and does not guarantee Replied, post #74 · Devices › Pens & autoinjectors · 17 Nov 2025 · 15 likes post #73 answers the question as asked. The question underneath it is different. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #76 · Analytics › HPLC & UHPLC · 4 Nov 2025 · 19 likes This follows post #73 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #101 · Practice › Storage & stability · 24 Oct 2025 · 0 likes post #100 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #3 · Outcomes › Body composition · 5 Oct 2025 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
A payment that went through twice: how it was resolved Replied, post #5 · Sourcing › Payments · 4 Oct 2025 · 2 likes Worth separating two things that the opening post runs together. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a…
-
MHRA statements, read directly Replied, post #6 · Regional › UK & Ireland · 21 Sep 2025 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Payment method and the leverage it gives you, ranked Replied, post #21 · Sourcing › Payments · 16 Sep 2025 · 21 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #115 · Evidence › Study critique · 16 Sep 2025 · 13 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #119 · Practice › Reconstitution · 5 Sep 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #86 · Compounds › Oral incretins · 21 Aug 2025 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. Why administration conditions matter for oral semaglutide and not for injectables:…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #44 · Practice › Side effects · 20 Aug 2025 · 2 likes post #43 answers the question as asked. The question underneath it is different. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance…
-
Why most self-reports here are not experiments, and that is fine Started this topic · Research Methods › N-of-1 designs · 17 Aug 2025 · 13 likes Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen…
-
Publishing an inconvenient result: a case study Replied, post #64 · Sourcing › Independent verification · 11 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #38 · Compounds › Retatrutide · 7 Aug 2025 · 22 likes Picking up post #35: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3…
-
Are there stupid questions here? A staff answer, at length Replied, post #41 · Start Here › Welcome · 5 Aug 2025 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Tracking that stops updating and then resumes Replied, post #15 · Sourcing › Logistics · 4 Aug 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Travel coolers and how long they really hold Replied, post #24 · Devices › Cold chain · 2 Aug 2025 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #78 · Compounds › Repair & healing peptides · 2 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Realistic expectations for strength while losing weight quickly Replied, post #11 · Nutrition & Training › Resistance training · 2 Aug 2025 · 22 likes Coming back to post #9, because the follow-up matters more than the original answer. Maintenance is the goal: preserving lean mass and strength during weight loss is…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 10 likes Coming back to post #35, because the follow-up matters more than the original answer. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #55 · Evidence › Journal club · 26 Jun 2025 · 1 like Picking up post #52: that is the part I would want checked first. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
Regression to the mean in progress reports Replied, post #22 · Research Methods › Statistics · 19 Jun 2025 · 14 likes On post #18 — agreed on the reasoning, with one qualification. Confounding: a third variable explains an apparent association. In randomised data, randomisation…
-
A report I filed that turned out to be wrong, and the correction Replied, post #109 · Sourcing › Vendor reports · 18 Jun 2025 · 3 likes post #108 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #12 · Documentation › Doc review · 13 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 9 Jun 2025 · 13 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
An emergency department visit, described afterwards Replied, post #28 · Safety › Adverse events · 6 Jun 2025 · 2 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Albumin binding and how it produces a long half-life Replied, post #35 · Pharmacology › Pharmacokinetics · 12 May 2025 · 4 likes post #34 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
A well-designed study with a badly written abstract Replied, post #63 · Evidence › Study critique · 5 May 2025 · 0 likes post #62 answers the question as asked. The question underneath it is different. Criticise the method, not the author: a paper with a weak design is not a bad paper by…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #57 · Access › Pricing · 7 Apr 2025 · 26 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #24 · Compounds › Tirzepatide · 12 Mar 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #120 · Compounds › Semaglutide · 4 Mar 2025 · 0 likes Coming back to post #118, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
What we do not know about retatrutide, listed explicitly Replied, post #62 · Compounds › Retatrutide · 19 Jan 2025 · 22 likes This follows post #59 rather than contradicting it. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #11 · Evidence › Preprints · 19 Jan 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #5 · Compounds › Repair & healing peptides · 10 Jan 2025 · 7 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
[2026 update] New subcategory: rationale and scope Replied, post #135 · Meta › Announcements · 9 Jan 2025 · 3 likes I read post #133 twice before replying, because I had assumed the opposite. Staff-only posts: some announcements are visible only to staff (concerning internal…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #15 · Practice › Reconstitution · 27 Dec 2024 · 3 likes post #14 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #2 · Compounds › Secretagogues & GH axis · 23 Dec 2024 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #14 · Data & Tools › Calculators · 9 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #45 · Compounds › Tirzepatide · 20 Nov 2024 · 0 likes Coming back to post #43, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
Transporting a vial for a weekend away Replied, post #25 · Practice › Storage & stability · 2 Nov 2024 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #15 · Pharmacology › Formulation chemistry · 24 Oct 2024 · 2 likes Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #28 · Compounds › Semaglutide · 19 Oct 2024 · 4 likes Worth separating two things that post #24 runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal…
-
Blind submission and why it changes minds Replied, post #91 · Sourcing › Independent verification · 18 Oct 2024 · 8 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #7 · Compounds › Retatrutide · 28 Aug 2024 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Why I ask for the gradient before I discuss the number Replied, post #11 · Analytics › HPLC & UHPLC · 5 Aug 2024 · 14 likes Picking up post #8: that is the part I would want checked first. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
-
Guidelines revision: what changed and why Replied, post #127 · Meta › Announcements · 28 Jul 2024 · 2 likes post #126 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
The mass-error checker and its intended scope Replied, post #156 · Data & Tools › Calculators · 26 Jul 2024 · 0 likes This follows post #153 rather than contradicting it. The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #102 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #15 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes I read post #13 twice before replying, because I had assumed the opposite. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Cold packs, phase-change material, and what survives ten days Replied, post #5 · Sourcing › Logistics · 10 Jun 2024 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…